Myriad Genetics Inc (MYGN)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Jun 30, 2020	Jun 30, 2019
Operating income	US$ in thousands	-257,400	-140,600	-190,500	-231,700	7,600
Revenue	US$ in thousands	745,400	675,200	846,000	627,800	840,000
Operating profit margin		-34.53%	-20.82%	-22.52%	-36.91%	0.90%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $-257,400K ÷ $745,400K
= -34.53%

Myriad Genetics, Inc. has experienced fluctuating operating profit margins over the past five years, as evidenced by the figures presented in the table. The company's operating profit margin deteriorated significantly from 1.02% in June 2019 to -21.11% in June 2020, representing a substantial decline in profitability. This negative trend continued in subsequent years, with operating profit margins remaining in negative territory, reaching -19.20% as of December 31, 2023.

The persistently negative operating profit margins indicate that Myriad Genetics, Inc. has been facing challenges in generating profits from its core operations relative to its revenue. A declining trend in operating profit margins can be concerning as it may signal inefficiencies, cost overruns, or pricing pressures within the company's operations.

Overall, the analysis suggests that Myriad Genetics, Inc. has been struggling to maintain profitability in recent years, as reflected in its deteriorating operating profit margins. It may be crucial for the company to address the underlying factors contributing to this trend in order to improve its financial health and operational performance going forward.